Solstice Secures $21M Series A for Pharma Innovation
Getting a drug that might save lives through the development process and on to the market is a notoriously sluggish business, but a new software business in New York City
Getting a drug that might save lives through the development process and on to the market is a notoriously sluggish business, but a new software business in New York City
Venture capital firm Transition Ventures has announced the final closing of its 2nd flagship fund at $150m. The oversubscribed fund expands the firm’s total assets under management (AUM) to above
Series A Financing Strengthens Regenerative Medicine Strategy Secretome Therapeutics just landed $30 million in Series A funding, thanks mostly to RA Capital Management—those folks really know their way around healthcare
Cognition’s $1 Billion Raise Signals AI Engineering Surge Cognition has raised $1 billion in Series D financing at a $26 billion valuation. The company builds autonomous AI agents for software